CORE LABORATORIES N V Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Income from continuing operations
Income (loss) from discontinued operations, net of tax
Income (loss) from continuing operations
Income (loss) from discontinued operations, net of income taxes
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock-based compensation
Depreciation and amortization
Impairments, inventory write-down and other charges
Changes in value of life insurance policies
Deferred income taxes
Realization of pension obligation
Net (recovery) provision for doubtful accounts
Net provision for credit losses
Gain on sale of business
(Gain) loss on sale of discontinued operations
Other non-cash items

Changes in assets and liabilities, net of effects of acquisitions and divestures:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued expenses
Unearned revenue
Other liabilities
Net cash provided by operating activities

CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures
Patents and other intangibles
Acquisitions, net of cash acquired
Distribution received from life insurance policies
Proceeds from sale of assets
Proceeds from sale of business, net of cash sold
Proceeds from insurance recovery
Proceeds (payment) from sale of discontinued operations
Net proceeds (premiums) on life insurance policies
Net cash provided by (used in) investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Excess tax benefits from stock-based payments
Repayment of long-term debt
Proceeds from long-term debt
Proceeds from issuance of common shares
Transaction costs on equity distribution program
Debt issuance costs
Non-controlling interest - dividend
Dividends paid
Repurchase of common shares
Other financing activities
Net cash used in financing activities
NET CHANGE IN CASH AND CASH EQUIVALENTS

NET CHANGE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, beginning of year
CASH AND CASH EQUIVALENTS, end of year
Supplemental disclosures of cash flow information:
Cash payments for interest
Cash payments for income taxes
Non-cash investing and financing activities:
Capital expenditures incurred but not paid for as of the end of the year

Comments